Filed under: Pfizer (PFE), Stocks to Buy
I really wish I had several thousand dollars to play with right about now. If I did, I'd plunk the entire wad down on Medivation (MDVN) and let it ride.
Why would I do that? My reasoning is simple. I'd do that because the recent sell-off of Medivation, on the heels of a disappointing phase 3 study of the drug dimebon (latrepirdine) absolutely blew the floor out from under the company's shares. I'm telling you right now, I believe that sell-off has gone twice as deep as good sense can justify. At least, that's the way I see it.
Continue reading What's Up with Medivation?
What's Up with Medivation? originally appeared on BloggingStocks on Sat, 06 Mar 2010 14:10:00 EST. Please see our terms for use of feeds.
Permalink | Email this | CommentsFull story at http://www.pheedcontent.com/click.phdo?i=52ebe9d126de8592ceefb0aa38a233a4
No comments:
Post a Comment